why do scientific enterprises choose L7?

latest news

L7 Informatics Raises $38 Million Growth Investment to Digitalize Precision...

L7 Informatics announced a $38 million investment led by Banneker Partners with participation from its pre-existing investors.
webpage

L7 Informatics and Triumvira Immunologics Sign Manufacturing Digitilization Deal

L7 Informatics and Triumvira Immunologics agreed to implement L7|ESP at Triumvira to enhance the digitalization of its manufacturing of next-generation
webpage

L7 Informatics and Triumvira Immunologics Announce Agreement to Digitalize Manufacturing...

L7 Informatics and Triumvira Immunologics today announced an agreement to implement L7|ESP at Triumvira to enhance the digitalization of its
webpage

The Jackson Laboratory Goes Live with L7|ESP Data+Intelligence Unified Platform

L7 Informatics announced that The Jackson Laboratory (JAX) has gone live with the L7|ESP platform, providing the environment for scientists
webpage

recent case studies

PACT Pharma: Cell & Gene Therapy Platform

The implementation of L7|ESP across comPACT and imPACT neo TCR-T cell manufacturing and all upstream and downstream QC processes.
document
Case Study

QIAGEN: Trustworthy by Design

The automation of the entire laboratory workflow, from sample to insight, and the selection of the miRNA NGS assay development
document
Case Study

ARMI: Regenerative Medicine

The digitalization of one of ARMI’s compartmentalized manufacturing processes into a seamless digital twin that automates process and operations data
document
Case Study

Rady Children’s Institute: Bedside Genomic Program

The set-up of a successful bedside genomics program in a health system through digitalization and automation of rapid whole genome
document
Case Study

upcoming events

AGBT Precision Health 2022

09/08/22-09/10/22
San Diego, CA
BOOK A MEETING

Fierce Biotech Summit

09/19/22-09/20/22
Boston, MA & Live Streaming
BOOK A MEETING

Biotech Week Boston

09/27/22-09/30/22
Boston, MA
BOOK A MEETING

Lab of the Future Europe 2022

10/04/22-10/05/22
Amsterdam, The Netherlands
BOOK A MEETING

Cell and gene on the Mesa

10/11/22-10/13/22
Carlsbad, CA
BOOK A MEETING

ASHG Annual Meeting​

10/25/22-10/29/22
Los Angeles, CA
BOOK A MEETING

BioTechX

11/08/22-11/10/22
Basel, Switzerland
BOOK A MEETING

Reuters Pharma Awards USA 2022

12/01/22-12/01/22
Philadelphia, PA
BOOK A MEETING

L7 | CHATS

L7 Releases L7|ESP 3.0 with New Features and Updates

We are pleased to officially announce the release of L7|ESP version 3.0. This release includes new features and updates in
document
Blog

L7 | ESP 3.0

The next release of L7|ESP is on the horizon, with new + enhanced functionality to benefit all L7|ESP customers.​
document
Blog

JAX® goes live with L7|ESP

L7 Informatics announced that The Jackson Laboratory (JAX) has gone live with the L7|ESP platform, providing the environment for scientists
document
Blog

L7|ESP; Data+Intelligence for the Scientific Enterprise

L7 Informatics aspires to help life-sciences, research, and manufacturing organizations accelerate success in today’s data-driven world.
document
Blog

L7 culture

 

At L7, we aspire to do great things. L7's innovation is fueled by an interdisciplinary team of scientists, engineers, and operations-research experts. L7'ers are passionate about our technology with a desire to make a positive impact on improving the speed, efficiency, and progression of healthcare and life sciences organizations around the world. L7 is growing fast, and we are looking for potential colleagues that are as inspired and motivated as we are!

L7 was the right decision. We are very pleased, and I highly recommend L7 Informatics.

Ashish Kheterpal, CIO, PACT Pharma

L7|ESP is an adaptable and customizable platform that streamlines process execution, provides a complete chain of custody from sample to report, and enables management of complex workflows.

Simon Hughes, Associate Director, CDx Assay Development, QIAGEN

L7 plays a key role in our end-to-end automation of the patient journey - from order to clinical report.

Dr. Stephen Kingsmore, President/CEO, Rady Children's Institute for Genomic Medicine

L7|ESP provides a single platform to assure both control and compliance, while providing a seamless transfer of clinical operations to manufacturing operations.

Ernie Bognar, Chief Operations Officer, Gradalis, Inc.

L7|ESP brought organization and efficiency to our advanced data analytics efforts

Thomas Bollenbach, Ph.D., CTO, ARMI